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ABSTRACT 
The concept of mixed solvency is an emerging field which can serve as a milestone for solubility enhancement and therefore 
deserves an urgent attention of the scientific community to assess its efficiency and applicability. Mixed solvency concept suggested 
that each substance present on the earth whether solid, liquid or gas has solubilizing power. In mixed solvency concept each 
substance (gas, liquid or solid) is termed as solubilizer. Solubility enhancement by a single solubilizer in high concentration may 
raise the toxicity concern. Mixed solvency concept gives solution to this problem. Several solubilizers in small concentration in a 
blend may give desired solubility for a given drug and hence may be safe (non-toxic). In future, the industries shall use the 
solubilising properties of different additives for such purpose. The described research is one typical example where safe 
concentrations of additives have been used to prepare a dry injection for reconstitution of aspirin (a poorly water soluble drug)   
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INTRODUCTION: 
As we know that all materials which exist in liquid state 
are known as solvents like water, chloroform, methanol, 
propylene glycol, dimethyl formamide, dimethyl 
sulfoxide, ethanol, benzene etc. No solvent is universal 
solvent. In other words, we can say that although these 
all liquids are known as solvent but they are not good 
solvents for all solutes. For example we know that water 
is good solvent for about one third drugs and bad solvent 
for about two third drugs. Thus we can say that all 
liquids are good solvent for some solutes and bad 
solvents for other solutes. Similarly, in mixed solvency 
concept 
1
 each and every substance (gas, liquid or solid) 
is good solubilizer for some solutes and bad solubilizer 
for other solutes. 
MATERIALS AND METHODS: 
Aspirin was procured as a gift sample from Shree 
Pharmaceuticals Indore. Lignocaine hydrochloride and 
niacinamide were procured from Modern Laboratories, 
Indore.   
Experimental    
Solubility studies 
Approximate solubility studies were carried out to 
determine the solubilities of seven drugs in an aqueous 
blend containing safe solid additives of injection in safe 
concentration (reported in literature). The solubilising 
efficiencies of these additives were evaluated. The 
aqueous blend (B) contained 5% w/v sodium benzoate (a 
safe buffering agent), 5% w/v PVP K30 (a plasma 
expander), 2.5% w/v niacinamide (a safe stabilizer), 
7.5% w/v PEG 4000 (a safe solubilizer) and 5% w/v 
lignocaine hydrochloride (a safe local anesthetic). 
Approximate solubilities of drug were determined by 
shaking the excess of drug with 10 ml of the blend for 
about 20 minutes in a bottle and then filteration was 
done. Approximately saturated solution of aspirin was 
analysed by titration with 0.1N NaoH using 
phenolphthalein indicator. For remaining drugs, 
spectrophotometric estimation were done. Approximate 
solubilities of all seven drugs are reported in Table 1.  
Table 1 also gives solubilities of drug in distilled water 
at room temperature. Approximate solubility of aspirin 
in distilled water at room temperature was obtained by 
shaking excess of aspirin with about 60 ml of distilled 
water in a bottle for about 20 minutes. It was then 
filtered and filtrate was analyzed titrimetrically. Result is 
presented in Table 1. The solubilities of remaining six 
drugs were taken from research papers. 
Out of seven drugs studies, aspirin was selected for 
further study. A model dry injection of aspirin was 
developed. Although aspirin has about 8.811% w/v 
solubility in the blend (B), an injection was developed 
having 5% w/v strength of aspirin. Thus 2ml of such 
solution contains 100 mg of aspirin. 
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Table 1: Solubilities and solubility enhancement studies 
S.No Name of drug Solubility in distilled water 
at room temperature 
(% w/v) 
Solubility in blend (B) 
at room temperature 
(%w/v) 
Solubility 
enhancement 
ratio 
1 Aspirin 0.331 8.811 26.6 fold 
2 Norfloxacin 0.088 0.652 7.4 fold 
3 Naproxen 0.009 5.745 638.3 fold 
4 Tinidazole 0.538 1.206 2.2 fold 
5 Piroxicam 0.040 0.994 24.8 fold 
6 Frusemide 0.064 2.013 31.4 fold 
7 Indomethacin 0.036 3.009 83.6 fold 
  
Formulation development of dry injection 
Approximate solubility of aspirin in distilled water is 
0.33 % w/v at room temperature. Approximate solubility 
of aspirin in an aqueous solution (a mixed solvency 
blend) containing 5% w/v sodium benzoate, 5% w/v 
lignocaine hydrochloride, 5% w/v PVP K30, 7.5% w/v 
PEG 4000 and 2.5% w/v niacinamide is 8% w/v. Thus a 
5% w/v solution of aspirin can be made easily in the 
above mentioned mixed solvency blend. Hence, 2ml of 
such solution shall contain 100 mg of aspirin. It is 
evident from the literature that 5% w/v sodium benzoate 
is safely employed buffering agent in injections. PVP 
K30 is a plasma expander; therefore, 5% w/v PVP K30 
is safe in injections. In this case lignocaine 
hydrochloride is an additive (local anesthetic to reduce 
the pain of injection). PEG 4000, an additive 
(solubilizer) is safe in 7.5% w/v concentration in 
injections. Niacinamide (2.5% w/v) is a safely used 
stabilizer in injections. Thus, all five solid additives are 
present in safe concentrations in mixed solvency blend. 
Because of the solubilising effect of all five solids, the 
solubility of aspirin is enhanced tremendously and an 
aqueous injection can be developed to contain 100 mg 
aspirin in 2 ml of the blend. A dry injection of aspirin 
can nicely be developed to have very good chemical 
stability in the form of dry injection for reconstitution. 
Table 2 gives a formula for model dry injection of 
aspirin. Aspirin, 100 mg (sieved through fine sieve), 
lignocaine hydrochloride, 100 mg (sieved through fine 
sieve), niacinamide, 75 mg (sieved through fine sieve), 
PEG4000, 150 mg (fine powder), sodium benzoate, 100 
mg (sieved through fine sieve) and PVP K30, 100 mg 
(sieved through fine sieve) are kept in a 5ml vial. When 
2 ml distilled water is added in the vial and vial is 
shaken vigourously, a clear solution is obtained. This 
experiment explains that a dry injection of poorly water 
soluble drug, aspirin, can be developed using 
solubilising power of all five solid solubilizers. 
Chemical stability studies and toxicological studies shall 
have to be performed to develop a drug injection for 
reconstitution of aspirin. All materials used in this 
formula should be free from pyrogens and microbes. 
Containers should be sterile and aseptic room shall be 
employed during its manufacture. 
 
Table 2: Composition of model formulation 
S.No. Ingredients Quantity 
1 Aspirin (sieved through fine sieve) 100  mg 
2 Lignocaine hydrochloride (sieved through fine sieve) 100  mg 
3 PVP K30 (sieved through fine sieve) 100 mg 
4 Niacinamide (sieved through fine sieve) 75 mg 
5 PEG4000 (powder) 150 mg 
6 Sodium benzoate (sieved through fine sieve) 100 mg 
 
CONCLUSION: 
Mixed solvency concept can further be utilized for 
development of dry injections as well as dry syrups of 
various poorly water soluble drugs. In above research 
work it is important to note that drug selected is a model 
drug and solublizers are model solubilizers. 
Formulations of various insoluble drugs can be 
developed using mixed solvency technique. Similarly, 
several combinations of safely used additives may be 
used to make innumerable safe blends giving enhanced 
solubilities of poorly soluble drugs. 
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